Vimeo
LinkedIn
Instagram
Share |

pharmaceutical comapanies

September 21, 2009

The Fuhrer family, owners of the Israel-based pharmaceutical company Neopharm, has made an offer for the acquisition of the drug supplier Goldshield Group.

The Fuhrer family, owners of the Israel-based pharmaceutical company Neopharm, has made an offer for the acquisition of the drug supplier Goldshield Group.

The bid was made through AIT Investment, a company set up by the Fuhrer family for the purpose of acquiring Goldshield. It has offered 440 pence per share for the company, valuing it at £162 million.

Click here >>
Close